Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ANVS Annovis Bio Inc
- Stocks
- Healthcare
- NYSEAMERICAN: ANVS
Price (delayed)
$1.79
Market cap
$34.88M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.11
Enterprise value
$12.64M
Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down Syndrome (AD-DS).
Highlights
ANVS's equity has surged by 158% since the previous quarter
The EPS has surged by 59% year-on-year but it has declined by 4.5% since the previous quarter
The net income is up by 39% year-on-year but it is down by 18% since the previous quarter
Key stats
What are the main financial stats of ANVS
Market
Valuations
Earnings
Shares outstanding
19.49M
Market cap
$34.88M
Enterprise value
$12.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.45
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$25.17M
Net income
-$29.06M
EBIT
-$29.06M
EBITDA
-$29.06M
Free cash flow
-$22.96M
Per share
Balance sheet
Liquidity
EPS
-$2.11
EPS diluted
-$2.15
Free cash flow per share
-$1.32
Book value per share
$1.23
Revenue per share
$0
TBVPS
$1.53
Total assets
$26.74M
Total liabilities
$2.68M
Debt
$0
Equity
$24.05M
Working capital
$24.23M
Debt to equity
0
Current ratio
10.68
Quick ratio
8.88
Net debt/EBITDA
0.77
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-193.5%
Return on equity
-300.6%
Return on invested capital
N/A
Return on capital employed
-119.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ANVS stock price
How has the Annovis Bio stock price performed over time
Intraday
5.92%
1 week
16.99%
1 month
42.06%
1 year
-77.71%
YTD
-64.41%
QTD
19.33%
Financial performance
How have Annovis Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.17M
Net income
-$29.06M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 41% YoY and by 6% QoQ
The net income is up by 39% year-on-year but it is down by 18% since the previous quarter
Price vs fundamentals
How does ANVS's price correlate with its fundamentals
Growth
What is Annovis Bio's growth rate over time
Valuation
What is Annovis Bio stock price valuation
P/E
N/A
P/B
1.45
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 59% year-on-year but it has declined by 4.5% since the previous quarter
ANVS's equity has surged by 158% since the previous quarter
The price to book (P/B) is 83% less than the 5-year quarterly average of 8.3
Efficiency
How efficient is Annovis Bio business performance
The company's return on equity has surged by 74% YoY and by 66% QoQ
The return on assets is up by 48% year-on-year and by 19% since the previous quarter
Dividends
What is ANVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ANVS.
Financial health
How did Annovis Bio financials performed over time
ANVS's current ratio has soared by 197% from the previous quarter
Annovis Bio's total assets has surged by 92% QoQ
The company's debt is 100% lower than its equity
ANVS's equity has surged by 158% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.